COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02142959
Recruitment Status : Completed
First Posted : May 20, 2014
Last Update Posted : February 26, 2016
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015
Certification/Extension First Submitted : June 23, 2015